WaferGen Bio-Systems (WGBS) Reports In-Line Q3 EPS

WaferGen Bio-Systems (NASDAQ: WGBS) reported Q3 EPS of ($0.61), in-line with the analyst estimate of ($0.61). Revenue for the quarter came in at $2 million versus the consensus estimate of $2 million.

WaferGen Bio-Systems reaffirmed FY2015 guidance.

For earnings history and earnings-related data on WaferGen Bio-Systems (WGBS) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance